Monoclonal antibody testing for fecal calprotectin is superior to polyclonal testing of fecal calprotectin and lactoferrin to identify organic intestinal disease in patients with abdominal discomfort

Clin Chim Acta. 2013 Feb 1:416:41-7. doi: 10.1016/j.cca.2012.11.008. Epub 2012 Nov 21.

Abstract

Background and aims: Fecal calprotectin and lactoferrin are sensitive markers of mucosal inflammation. We compared three different assays in their ability to identify patients with organic intestinal disease.

Methods: In a post-hoc analysis of a prospective study, we examined 405 unselected patients with abdominal complaints referred for endoscopy to the University Hospital Basel, Switzerland. Calprotectin (EK-CAL, Bühlmann Laboratories, Switzerland; PhiCal, Calpro AS, Norway) and lactoferrin (IBD-Scan, Techlab, USA) were measured using enzyme-linked immunosorbent assays. The presence of a clinically significant endoscopic finding was the primary endpoint of the study. Final diagnoses were adjudicated blinded to calprotectin values.

Results: The prevalence of organic intestinal disease was 35.3%. Receiver operating characteristics analysis calculated an area under the curve (AUC) for EK-CAL of 0.918, which was significantly better than for PhiCal (AUC 0.842, P<0.001) and IBD-Scan (AUC 0.830, P=0.003) to identify patients with organic intestinal disease. Overall test accuracy was 88.1% for EK-CAL, 83.7% for PhiCal, and 81.3% for IBD-Scan. Optimal cut-off value calculated for PhiCal and IBD-Scan were lower than recommended by the manufacturer.

Conclusions: Monoclonal testing of calprotectin is superior to both polyclonal calprotectin testing and fecal lactoferrin in identifying symptomatic patients with organic intestinal disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies / analysis
  • Antibodies, Monoclonal / analysis*
  • Biomarkers / analysis
  • Enzyme-Linked Immunosorbent Assay* / classification
  • Enzyme-Linked Immunosorbent Assay* / methods
  • Feces / chemistry*
  • Humans
  • Intestinal Diseases / diagnosis*
  • Intestinal Diseases / pathology
  • Lactoferrin / analysis*
  • Leukocyte L1 Antigen Complex / analysis*
  • Prospective Studies
  • ROC Curve
  • Switzerland

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Biomarkers
  • Leukocyte L1 Antigen Complex
  • Lactoferrin